Home › Funds › BAUPOST GROUP LLC/MA › PCVX
BAUPOST GROUP LLC/MA position in PCVX
VAXCYTE INC · Health Care
BAUPOST GROUP LLC/MA reported holding 800,000 shares of PCVX (VAXCYTE INC) in its Q1 2026 13F filing — a position valued at US$46.5M, representing 0.91% of its reported portfolio and ranking #21 among its reported holdings. BAUPOST GROUP LLC/MA first reported this position in Q1 2026.
Last updated: 2026-10-23 · Source: SEC EDGAR Form 13F-HR
How BAUPOST GROUP LLC/MA's PCVX position evolved
BAUPOST GROUP LLC/MA first disclosed a stake in PCVX in Q1 2026 at 800,000 shares (US$46.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 800.00K | $46.49M | New |
About PCVX and 13F data
PCVX (VAXCYTE INC) is a Health Care company. 36 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCVX
- Jupiter Topco LLC 17.97M sh · $1.04B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- T. Rowe Price Investment Management, Inc. 12.21M sh · $709.62M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 11.47M sh · $667.02M · Q2 2026
- Deep Track Capital, LP 4.30M sh · $249.96M · Q2 2026
- Kynam Capital Management, LP 2.92M sh · $169.88M · Q2 2026
- Caligan Partners LP 2.19M sh · $127.23M · Q2 2026
- Paradigm Biocapital Advisors LP 2.13M sh · $123.69M · Q2 2026
- Bellevue Group AG 1.97M sh · $114.63M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- MAVERICK CAPITAL LTD 1.61M sh · $93.78M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.43M sh · $82.86M · Q2 2026
More on BAUPOST GROUP LLC/MA
FAQ
How long has BAUPOST GROUP LLC/MA held PCVX?
BAUPOST GROUP LLC/MA has disclosed PCVX holdings in 1 of the last 1 reported quarters, going back to Q1 2026.
What is BAUPOST GROUP LLC/MA's current position in PCVX?
As of Q1 2026, BAUPOST GROUP LLC/MA holds 800.00K shares of PCVX (VAXCYTE INC), valued at $46.49M, representing 0.91% of its reported portfolio and ranking #21.
Has BAUPOST GROUP LLC/MA been buying or selling PCVX?
In the latest 13F filing (Q1 2026), BAUPOST GROUP LLC/MA newly opened its position in PCVX.
Which other funds hold PCVX?
Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.